REVIEW
|
doi:10.20944/preprints202306.1955.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
breast cancer; CDK4/6 inhibitors; estrogen receptor; therapeutic resistance
Online: 28 June 2023 (07:39:44 CEST)